Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ALDX
ALDX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ALDX News
Aldeyra Therapeutics Faces Securities Investigation
1d ago
Globenewswire
Rosen Law Firm Investigates Aldeyra Securities Claims
4d ago
PRnewswire
Investigation into Aldeyra Therapeutics Securities Claims
5d ago
Globenewswire
Insider Purchases at Greene County Bancorp and Aldeyra Therapeutics
Mar 23 2026
NASDAQ.COM
Aldeyra Therapeutics Faces Securities Investigation Over Misleading Information
Mar 22 2026
Globenewswire
Aldeyra Therapeutics Faces Securities Investigation
Mar 21 2026
PRnewswire
Aldeyra's Dry Eye Drug Application Denied by FDA
Mar 20 2026
PRnewswire
Aldeyra's Reproxalap Faces FDA Rejection Due to Efficacy Issues
Mar 18 2026
PRnewswire
Block & Leviton Investigates Aldeyra Therapeutics for Securities Violations
Mar 17 2026
Globenewswire
Aldeyra Therapeutics Shares Plunge 75% After FDA Response on Dry Eye Treatment
Mar 17 2026
stocktwits
Aldeyra's Lead Drug Reproxalap Fails FDA Approval Again
Mar 17 2026
seekingalpha
Aldeyra Receives Complete Response Letter from FDA for Reproxalap NDA
Mar 17 2026
Newsfilter
Trump Weighs Options for Action on Iran
Mar 16 2026
stocktwits
Retail Sentiment on ALDX Remains Bearish Amid Approval Uncertainty
Mar 11 2026
stocktwits
Overview of FDA Regulatory Developments
Feb 25 2026
NASDAQ.COM
Surge in Options Trading Volume for ACMR and ALDX
Feb 11 2026
NASDAQ.COM
Show More News
